{"title":"Pharmacological effect of sodium-glucose cotransporter 2 inhibitors in reducing the incidence of nephrolithiasis","authors":"Arash Najafian, Sadaf Esteki","doi":"10.34172/jpd.2023.11220","DOIUrl":null,"url":null,"abstract":"Nephrolithiasis is one of the common diseases without effective treatment, the incidence of which has increased in the world in recent decades. Sodium-glucose co-transporter 2 inhibitor can reduce the probability of nephrolithiasis in diabetic and non-diabetic people.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"150 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Parathyroid Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jpd.2023.11220","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Nephrolithiasis is one of the common diseases without effective treatment, the incidence of which has increased in the world in recent decades. Sodium-glucose co-transporter 2 inhibitor can reduce the probability of nephrolithiasis in diabetic and non-diabetic people.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
